Show simple item record

dc.contributor.authorEryilmaz, Gul
dc.contributor.authorHizli Sayar, Gokben
dc.contributor.authorOzten, Eylem
dc.contributor.authorGogcegoz Gul, Isil
dc.contributor.authorIsiten, Nuket
dc.contributor.authorBagci, Eda
dc.contributor.authorYorbik, Ozgur
dc.date.accessioned2014-10-14T16:15:35Z
dc.date.available2014-10-14T16:15:35Z
dc.date.issued2014
dc.identifier.citationFollow-up study of children whose mothers were treated with transcranial magnetic stimulation during pregnancy: Preliminary results.G. Eryılmaz, G. Hızlı Sayar, E. Özten, I. G. Gül, Ö. Yorbik, H. N. İşiten, E. Bağcı. Neuromodulation: Technology at the Neural Interface. 2014. DOI: 10.1111/ner.12231tr_TR
dc.identifier.urihttp://earsiv.uskudar.edu.tr/xmlui/handle/123456789/274
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/25257229
dc.description.abstractObjectives: The purpose of this study is to determine the impact of repetitive transcranial stimulation (rTMS) treatment during pregnancy on neurodevelopment of children. Materials and Methods: Women who were treated with rTMS during pregnancy and delivered liveborn children between 2008 and 2013 were selected. A control group consisted of children whose mothers had a history of untreated depression during their pregnancy (N = 26). Early developmental characteristics of all the children in the study were evaluated, and their developmental levels were determined using the Ankara Developmental Screening Inventory. Results: The mean age of the children in the rTMS treatment group was 32.4 months (range 16–64 months), and that of the untreated group was 29.04 (range 14–63 months). Jaundice (N = 2) and febrile convulsion (N = 1) were the reported medical conditions in the children of the rTMS-treated group; jaundice (N = 3) and low birth weight (N = 1) were reported in the untreated group. In the rTMS group, mothers’ perception of delay in language development was observed, but there were not any statistically significant differences in the prevalence rate compared with the untreated group (OR = 0.38; 95% CI 0.0860–1.6580). Conclusions: Our results suggest that rTMS exposure during pregnancy is not associated with poorer cognitive or motor development outcomes in children aged 18–62 months. Although language development as reported by the mothers was found to be poorer than expected in the rTMS-treated group, the delay was found to be similar to the language delay observed in offspring otr_TR
dc.language.isoengtr_TR
dc.relation.ispartofseriesSCI;
dc.relation.isversionof10.1111/ner.12231tr_TR
dc.subjectLanguagetr_TR
dc.subjectneurodevelopmenttr_TR
dc.subjectsafetytr_TR
dc.subjectpregnancy outcomestr_TR
dc.subjecttranscranial magnetic stimulationtr_TR
dc.titleFollow-Up Study of ChildrenWhose MothersWere TreatedWith Transcranial Magnetic Stimulation During Pregnancy: Preliminary Resultstr_TR
dc.typeArticletr_TR
dc.relation.journalTechnology at the Neural Interfacetr_TR
dc.contributor.departmentÜsküdar Üniversitesi, İnsan ve Toplum Bilimleri Fakültesi, Psikoloji Bölümütr_TR
dc.contributor.authorIDTR107927tr_TR


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record